baber/WOPTO huggingface dataset:
Patent NZ-298490-A (NZ)
Title: Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors
Inventor: MCCLAY ALLEN
IPC: A61K9/00
Filed: 1995-12-19
Abstract: Described is an intravaginal drug delivery device for administration to a female mammal of certain 17'beta'-oestradiol precursors at a substantially constant rate for a period of at least three weeks. The 17'beta'-oestradiol precursor is a 17'beta'-oestradiol moiety in which the, or each, hydroxyl group of the 17'beta'-oestradiol moiety is blocked by a blocking group, which blocking group is readily removed from the 17'beta'-oestradiol moiety in vivo. The 17'beta'-oestradiol precursor must either have a solubility in liquid silicone of not less than 0.1 mg/100 ml or have a standard k value of not less than 0.1 'mu'g/day/mm. The 17'beta'-oestradiol precursor must also have a solubility in distilled water of not less than 1'mu'g/100 ml.
Patent NZ-330252-A (NZ)
Title: Cable support with head for supporting cable and engagement teeth on base to fit in groove, typically for office workstation
Inventor: WAISBROD NEVILLE
IPC: H02G3/32
Filed: 1998-04-22
Abstract: A cable support according to figure 2 for supporting cables from furniture which has a groove with side walls provided with side walls provided therein, the cable support including: a) a holding portion b) a mounting portion with one or more teeth where the portion or teeth being shaped for insertion into the groove in a first orientation of the cable and support further, the one ore more teeth being shaped for penetration with one or both of the side walls of the groove upon rotation of the cable support about an axis of rotation from the first orientation to a second orientation.
Patent NZ-334546-A (NZ)
Title: Erythropoietin receptor agonist and use in the treatment of hematopoietic disorders
Inventor: MCWHERTER CHARLES A
IPC: C12N5/0789
Filed: 1997-10-23
Abstract: Human EPO receptor agonist polypeptides are provided.  These polypeptides are produced by expression in a host cell and may be used in a method for selective ex vivo expansion of erythroid progenitors and for stimulating the production of hematopoietic cells in a patient having a hematopoietic disorder.
Patent NZ-337663-A (NZ)
Title: Tool having replaceable portion, typically hacksaw blade, attached to handle and having protective guide through which portion and handle are moved against resilient bias
Inventor: HAWKETTS GEOFFREY
IPC: B27B21/04
Filed: 1999-09-03
Abstract: Tool 1 has replaceable blade 11 fixed at one end to main body portion 4 having handle 3. Portion 4 receives one end of blade protection apparatus 9 which guides and aligns the blade as it cuts material, typically steel pipe. Spring 18 provides minimal blade exposure while facilitating blade cutting.
Patent NZ-501132-A (NZ)
Title: Inductive heating method and apparatus with cans being rotated as they are passed longitudinally through induction heating coils
Inventor: RUTLEDGE PETER JOHN
IPC: A23L3/04
Filed: 1998-05-08
Abstract: A method and apparatus (10) for the heating of convective material contained within the lumen of an inductive heating coil (12, 15, 16, 17) such that the cans (20) are rotated about their axes as they are heated. When the cans (20) are to be heated above the boiling point of their contents the cans (20) are passed through a rotary pressure lock (13, 19, 22) so that the heating of the contents of the cans (20) occurs under a super-atmospheric pressure.
Patent NZ-501452-A (NZ)
Title: Compositions for treating and preventing arterial thrombosis and use of a factor Xa inhibitor combined with a platelet antiaggregating agent
Inventor: BERNAT ANDRE
IPC: A61K45/00
Filed: 1998-06-09
Abstract: The use of direct or indirect selective inhibitors of the Xa factor acting via antithrombin III, combined with one or several compounds with platelet antiaggregating activity, for preparing medicines for preventing or treating arterial thromboembolism.
Patent NZ-501610-A (NZ)
Title: A collet type releasable sealing plug having an annular recess and sealing means
Inventor: STEBLINA DAVID
IPC: F16L55/132
Filed: 1998-05-11
Abstract: A releasable plug (1) for sealing an open end of a fluid bearing pipe (17) having at its open end (17a) an inwardly directed flange (18) formed upon cutting an end of pipe (17), comprising a plug body (12), an annular recess formed in the body which engages said flange (18), and sealing means (7) which frictionally engages an inner surface of pipe (17) providing a pressure seal for pipe (17).
Patent NZ-506115-A (NZ)
Title: Contraceptive kit containing a compound with both estrogenic and progestagenic activity
Inventor: KLOOSTERBOER HELENIUS JAN
IPC: C07J1/00
Filed: 1999-03-03
Abstract: A steroid compound having an activity profile combining progestagenic and estrogenic activity can be used for the daily administration of a single contraceptive agent. Preferably the compound is the compound of formula I wherein the dotted lines each independently indicate an optional additional bond.
Patent NZ-512653-A (NZ)
Title: A lock for a sliding door with a pivoting pull tab with gripping flange and mounted to the face plate
Inventor: FORTUNE GEOFFREY JAMES
IPC: E05B65/08
Filed: 2000-12-21
Abstract: A lock having a face plate 16 for mounting to an edge of a door 12, and a locking bolt 22 with an end adapted to extend from the face plate 16. A pivoting pull tab 36 is mounted to the face plate 16 at one end with an opening 39 to allow the bolt 22 to pass through. The distal end of the pull tab has a gripping flange 40 and the face plate 16 includes a recess 42 to allow for fingers to hold the gripping flange 40 and pivot the pull tab 36 in order to pull the door 12 toward a closed position.
Patent NZ-517133-A (NZ)
Title: Removable chuck
Inventor: GIFFORD ROBERT H
IPC: B25B23/00
Filed: 2002-02-11
Abstract: A removable chuck (20) has a chuck member for holding a drill bit. Also, a mechanism (60) is coupled with the chuck body to retain the chuck body to a drill spindle (24). The retention mechanism, in a first position, has at least one biased blade, in a nonbiased condition, retaining the chuck on the drill spindle and in a second position, with the at least one biased blade in a biased condition, the chuck is enabled to be removed from the spindle.
Patent NZ-519425-A (NZ)
Title: Solutions containing epinastin
Inventor: TRACH VOLKER
IPC: H02K33/04
Filed: 2000-10-14
Abstract: Use of an aqueous solution comprising epinastine, optionally in the form of its racemate or its enantiomers and optionally in the form of the pharmacologically acceptable acid addition salts thereof, in the manufacture of a medicament for the treatment of late phase allergic reactions of the eye or nose by topical administration.
Patent NZ-520061-A (NZ)
Title: Terminal for executing an application program where notification of the source of the application program is displayed and repeater
Inventor: YAMADA KAZUHIRO
IPC: G06F9/445
Filed: 2001-12-11
Abstract: A terminal device comprises: a storage means for storing applications; writing control means for writing an application to the storage means and when the application to be stored satisfies a predetermined condition writing a corresponding identifier associated with the application into the storage means and application executing means for executing an application stored in the storage means and for indicating to a user a predetermined notification on the basis of the identifier corresponding to the application. The predetermined condition can be such as whether the application was downloaded from a network or whether the application includes information indicating that it is guaranteed by a third party which is different from a provider of the data. A relay device for relaying data between a first network and a second network comprises receiving means for receiving data from the first network and forwarding means for forwarding data received by the receiving means to the second network and for adding a predetermined identifier to the data when reliability of the data is not assured by a third party which is different from a provider of the data.
Patent NZ-523076-A (NZ)
Title: Indole derivatives having affinity for dopamine D4 receptor and their use for the treatment of psychiatric or neurologic disorders
Inventor: BANG-ANDERSEN BENNY
IPC: A61P25/16
Filed: 2001-06-13
Abstract: Dopamine and serotonin receptor ligands of formula (I) are disclosed, wherein one of Y1 and Y2 is N, which is bound to Y4, Y3 is Z-CH2, CH2-Z or CH2CH2 and the further meanings of Y1, Y2, Y3, Y4, Z, W, n, m, X, R1-R9 and R10 are as described in the specification. The compounds of formula (I) are useful in the treatment of certain psychiatric and neurological disorders, i.e. schizophrenia, other psychoses, anxiety disorders, depression, migraine, cognitive disorders, ADHD and sleep improvement.
Patent NZ-524839-A (NZ)
Title: Alignment of ink cartridge in holder assures electrical contact
Inventor: SEINO TAKEO
IPC: B41J2/175
Filed: 2003-03-20
Abstract: An ink cartridge and ink cartridge holder for maintaining the relative position between the information reading section of the ink cartridge holder and the information storing unit of the ink cartridge, which should be aligned accurately, even if the ink cartridge has instability to the ink cartridge holder due to the variation in each products. The ink cartridge which supplies ink to the recording apparatus includes: a substantially rectangular parallel piped ink cartridge main body holding the ink, a connection electrode section provided on a part of a first side of the ink cartridge main body and including a connection terminal, an ink supply unit provided in a front surface which intersects the first wall, and a positioning section guiding a positioning member of the recording apparatus to the vicinity of the connection electrode on the front surface so that the positioning member opposes to the connection electrode section in the direction parallel with the connection electrode section.
Patent NZ-528454-A (NZ)
Title: Absorbent product with improved fit
Inventor: DREVIK SOLGUN
IPC: A61F5/44
Filed: 2002-04-08
Abstract: An absorbent product, such as a sanitary towel, comprises a stiffening element (6) which is intended to contribute to the three-dimensional shape of the product during its use. The stiffening element is in a plane state before use of the product and has a stiffness in the dry state of in the order of 1-15 N measured according to ASTM D 4032-82. The stiffening element has a width at the transition between the crotch portion (3) and the front portion (1) on the sanitary towel which is adapted to the distance between the muscle tendons of the wearer on both sides of the crotch of the wearer in the groin of the latter and which is of the order of 15-45 mm. The product has different stiffness along a centre line extending in the longitudinal direction thereof, as a result of which the product is predestined to curve in predetermined places along said centre line when the product is fitted on the wearer.
Patent NZ-530900-A (NZ)
Title: Composition and method for manipulating painted apple moth
Inventor: GRIES REGINE
IPC: A01M1/02
Filed: 2004-01-30
Abstract: Disclosed herein is a composition of molecules having, either singly or in selected blends, pheromone-type effects capable of manipulating the behaviour of the painted apple moth Teia anartoides, wherein the composition included (Z,Z)-6,9-heneicosadien-11-one and (6Z-9R,10S)-cis-9,10-epoxy-heneicosene. Also disclosed is a composition comprising a four component blend including the compounds (Z,Z)-6,9-heneicosadien-11-one, (6Z-9R,10S)-cis-9,10- epoxy-heneicosene, (E,E)-7,9-heneicosadien-6,11-dione and 6-hydroxy-(E,E)-7,9- heneicosadien-11-one.
Patent NZ-532716-A (NZ)
Title: Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
Inventor: DONSBACH KAI
IPC: A61P25/00
Filed: 2002-10-11
Abstract: Disclosed is a crystalline sodium salt of 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (which is also known as a crystalline sodium salt of Telmisartan), a method for the production thereof, and the use of the same for producing a pharmaceutical composition having an angiotensin-II antagonistic action.
Patent NZ-532764-A (NZ)
Title: Method for sealing a plastic spout
Inventor: LAST LAURENS
IPC: B65D77/30
Filed: 2002-10-10
Abstract: A method for sealing a plastic spout (150,170) between two foil walls of a pouch. The spout has a spout body, which forms a passage (153) for delivering a medium from the pouch and/or feeding a medium to the pouch. In a bottom part thereof, the spout, on opposite sides, forms a sealing zone for sealing to an adjoining foil wall. The sealing zones of the spout body are formed by thin, flexible sealing walls (158,159) which project downward from the spout body and between them delimit a substantially oval space. The sealing walls of the spout body each have a curvature over their entire length, such that each sealing wall is outwardly convex over its entire length with respect to an imaginary plane passing through the outermost ends, which adjoin one another, of the sealing walls. The sealing method comprises the step of pressing the foil walls onto the sealing walls using pressure-exerting means. The pressure-exerting means press the foil walls onto the sealing walls of the pouch without a support member internally supporting the sealing walls.
Patent NZ-534398-A (NZ)
Title: Trolley with two pivotally connected sections for carrying surfboards mounted in racks
Inventor: HATFULL MARK
IPC: B62B1/12
Filed: 2003-02-05
Abstract: A carrier for transporting surfboards and the like is disclosed. The carrier 100 includes two racks 300, 400 consisting of upwardly extending fingers 311, 411 mounted on a body 200 transported by wheels 500. The body consists of pivotally connected sections 210, 220, 230 to allow the carrier geometry to be adjusted for different board dimensions, or to be folded into a small amount of space to allow for easy transportation in a carry bag or within a vehicle.
Patent NZ-536466-A (NZ)
Title: Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
Inventor: BRINGE NEAL A
IPC: A23L1/30
Filed: 2003-04-17
Abstract: Disclosed are compositions and methods for reducing hypercholesterolemia, lowering cholesterol and reducing the risk of cardiovascular disease comprising an isolated oil body associated protein. Additionally foodstuffs comprising one or more oil body associated proteins have been added. The compositions may further comprises additive compounds such as a saponin, an isoflavone, a phospholipids and a carbohydrate.
Patent NZ-537064-A (NZ)
Title: Animal tag
Inventor: STEINFORT JOHN JAMES
IPC: A01K11/00
Filed: 2004-12-08
Abstract: A skin penetrating head comprises of a central supporting portion of moulded plastic material having at least two thin flanges extending beyond the central supporting portion. The two thin flanges having sharp edges and meeting at a sharp point forward of the supporting portion. The sharp edges of the two thin flanges each extending for a distance of at least 1mm and having a width of at least 1mm past the edge of the central supporting portion and a maximum thickness of 1mm. (62) Divided Out of 528412
Patent NZ-539751-A (NZ)
Title: Pyrimidine-4,6-dicarboxylic acid diamides for the selectively inhibiting collagenase (MMP 13)
Inventor: KLINGLER OTMAR
Filed: 2003-10-18
Abstract: Pyrimidine-4,6-dicarboxamides of formula (I) wherein the variables are as defined in the specification, that are suitable for the selective inhibition of collagenase (MMP 13) are disclosed. These pyrimidine-4,6-dicarboxamides can thus be used for the treatment of degenerative joint disease, cartilage loss following joint trauma or relatively long joint immobilization following a meniscus or patella injury or a ligament rupture, a disease of the connective tissue, a wound healing disturbance, a chronic disease of the locomotory apparatus or a cancer disease.
Patent NZ-543863-A (NZ)
Title: Hexahydropyridoisoquinolines as DPP-IV inhibitors
Inventor: BOEHRINGER MARKUS
IPC: C07D471/04
Filed: 2004-06-11
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Patent NZ-545503-A (NZ)
Title: Animal product free media and processes for obtaining a botulinum toxin
Inventor: DONOVAN STEPHEN
IPC: C12P21/02
Filed: 2004-08-25
Abstract: Disclosed is a method for obtaining a biologically active botulinum toxin, comprising the steps of: (a) providing a fermentation medium that is substantially free of an animal derived product, wherein the medium comprises a protein product derived from a vegetable; (b) culturing a Clostridium botulinum bacterium in the fermentation medium under conditions which permit production of a botulinum toxin, and; (c) recovering a biologically active botulinum toxin from the fermentation medium.
Patent NZ-546298-A (NZ)
Title: Immunogenic composition and method of developing a vaccine based on factor H binding sites
Inventor: KARP NELSON M
IPC: A61K39/02
Filed: 2004-10-25
Abstract: Provided is a composition including specified HIV-1 glycoprotein Factor H binding site and a pharmaceutically acceptable support capable of eliciting Th-1 immune response to HIV-1. Further provided is the use of the composition for the manufacture of a medicament for treating HIV and use of the composition to treat animals.
Patent NZ-548440-A (NZ)
Title: Bicycloester derivative inhibitng DPP-IV for treatment of diabetes or similar
Inventor: FUKUDA YASUMICHI
IPC: C07D207/16
Filed: 2005-02-01
Abstract: Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt thereof, wherein X is CH2, CHF, CF2, CHOH, S, or O, n is 1, 2, or 3, and R1 is as defined in the specification. Also disclosed is an intermediate of formula (2), wherein P1 is a protective group for an amino group, and the other substituents are as defined above. Also disclosed is the use of the compound for treating diabetes, diabetic complications, hyperinsulinemia, hyperglycemia, abnormal lipid metabolism, obesity, AIDS following infection with HIV-1, rejection following organ/tissue transplantation, multiple sclerosis, rheumatoid arthritis, inflammation, allergies, osteoporosis, psoriasis and lichen planus, benign prostatic hypertrophy, lung metastasis of breast and prostatic cancers, hypertension, diuresis, decreased myelosuppression, increased white blood-cell count or infectious diseases.
Patent NZ-553955-A (NZ)
Title: Method and system for vibration sensing power management
Inventor: LEIGH NIGEL
Filed: 2007-03-19
Abstract: A method and system for vibration sensing is provided. According to the method, the vibration level of a machine in a frequency band of interest is measured, the measured vibration level is compared with a user-selected reference vibration level, and an electronic component required for recording vibration data is powered up if the measured vibration level is greater than or equal to the reference vibration level. The system comprises vibration sensing elements that generate electrical vibration signals representing sensed vibrations, a circuit that generates an overall vibration level based on the electrical vibration signals, a reference setting device that variably sets or selects a reference vibration level, a comparator that compares the overall vibration level with the reference vibration level and a second circuit that is powered up to record the electrical vibration signals if the overall vibration level is greater than or equal to the reference vibration level.
Patent NZ-555287-A (NZ)
Title: Solid formulations of liquid biologically active agents such as propofol
Inventor: RAVENELLE FRANCOIS
IPC: A61K9/10
Filed: 2005-11-28
Abstract: Disclosed is a solid product suitable for reconstitution to an essentially clear, stable aqueous solution, comprising an intimate mixture of at least one amphiphilic copolymer which includes a hydrophilic part that comprises at least one member selected from the group consisting of poly(N-vinylpyrrolidone), poly(N-2-hydroxypropylmethacrylamide), poly(2-ethyl-2oxazoline), poly(glycidol), poly(2-hydroxyethylmethacrylate), poly(vinylalcohol), polymethacrylic acid derivatives, poly(vinylpyridinium), poly((ammoniumalkyl)methacrylate), poly((aminoalkyl)methacrylate) and combinations and derivatives thereof, and at least one liquid biologically active agent such as propofol loaded within said amphiphilic copolymer, in such a manner that said liquid biologically active agent is intimately associated with said amphiphilic copolymer in a substantially solid product; The aqueous solution which is produced by reconstituting the solid contains the biologically active agent as stable nanodispersions or micelles and is substantially free of organic solvent. Also disclosed is an apparatus and a process for preparing the solid product comprising forming an aqueous solution of at least one linear, branched or star-shaped amphiphilic copolymer, under conditions to achieve micelle or nanodispersion formation; adding the liquid biologically active agent to the solution to form a second mixture; and treating said second mixture under conditions effective to remove water, while forming a substantially solid product.
Patent NZ-565300-A (NZ)
Title: Sustained release of antiinfectives
Inventor: BONI LAWRENCE T
IPC: A61K31/407
Filed: 2006-07-19
Abstract: Disclosed is a liposomal aminoglycoside formulation comprising a liposome having a lipid bilayer and an aminoglycoside encapsulated therein, wherein the amount of the lipid by weight is less than or equal to the amount of the aminoglycoside by weight, the lipid bilayer comprises a neutral phospholipid and a sterol, and the liposome has a mean diameter of 0.1 to 0.5 microns.
Patent NZ-565496-A (NZ)
Title: Methods for the preparation of HCV polymerase inhibitors
Inventor: MATTHEWS CHRISTOPHER FREDERICK
IPC: A61K31/519
Filed: 2006-08-16
Abstract: Disclosed is a crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7- dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one exhibiting any one of a characteristic peak in the powder x-ray diffraction pattern, expressed in degrees two-theta, selected from of about 7.1 or of about 12.1 or of about 16.1 or of about 17.5 or of about 23.5. Also disclosed is a composition comprising said crystalline form, the use of said crystalline form in the manufacture of a medicament for treating Hepatitis C virus and intermediate (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-ylethyl) derivatives employed in the preparation of the said crystalline form.